Your browser doesn't support javascript.
loading
Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles.
Liu, Juan; Hu, Xixue; Jin, Shubin; Liang, Xing-Jie; Ma, Xiaowei.
Afiliação
  • Liu J; National Center for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. maxiaowei@cau.edu.cn.
  • Hu X; Hepato-Pancreato-Biliary Center, Translational Research Center, Beijing Tsinghua Changgung Hospital, School of Medicine, Tsinghua University, Beijing, China.
  • Jin S; CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing, 100190, China. liangxj@nanoctr.cn.
  • Liang XJ; Beijing Municipal Institute of Labour Protection No. 55 Taoranting Road, Xicheng District, Beijing 100054, P. R. China.
  • Ma X; CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing, 100190, China. liangxj@nanoctr.cn.
J Mater Chem B ; 10(3): 384-395, 2022 01 19.
Article em En | MEDLINE | ID: mdl-34935843
ABSTRACT
Rapid release and clearance of antitumor drugs in vivo are the main factors used to evade the effectiveness of chemotherapeutics. Targeted delivery and controlled release of drugs are the most pressing dilemmas in cancer therapy. Herein we report the design and fabrication of multifunctional mesoporous silica nanoparticles coated with poly(N-isopropylacrylamide)-co-acrylic acid and calcium phosphate (MSCNs) with pH-triggered chemotherapeutic release and dual-targeting functions. By decorating the nanoparticle surface with a transferrin (Tf)/RGD ligand, these nanoparticles are capable of not only recognizing the intrinsic pH difference between tumor and normal tissues, but also targeting the lesion location. It was shown that Tf/RGD-MSCNs delivered the anti-tumor drug doxorubicin more efficiently into lysosomes and the resulting DOX-loaded nanoparticles (DOX-Tf/RGD-MSCNs) showed a stronger inhibitory effect towards tumor cell growth than free DOX and DOX delivered by unmodified MSNs. Moreover, the nanoparticles are more biocompatible than uncoated mesoporous silica nanoparticles. All these results indicate that Tf/RGD-MSCNs have great potential as a novel drug carrier in therapeutic applications against cancers.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatos de Cálcio / Portadores de Fármacos / Doxorrubicina / Dióxido de Silício / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatos de Cálcio / Portadores de Fármacos / Doxorrubicina / Dióxido de Silício / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article